Methylprednisolone Pediatric Dose — Steroids
Methylprednisolone is a synthetic glucocorticoid that exerts potent anti-inflammatory and immunosuppressive effects by binding intracellular steroid receptors and modulating gene transcription. It is used across a wide range of pediatric indications including inflammatory conditions, allergic reactions, and acute spinal cord injury (SCI). In the critical care setting, IV methylprednisolone provides rapid systemic corticosteroid activity with a favorable potency-to-mineralocorticoid side-effect profile.
Pediatric Dosing
General IV Corticosteroid Dosing
- 2 mg/kg/day IV divided every 6–12 hours
- Usual maximum: 60 mg/dose every 12 hours
For a 20 kg child: 20 × 2 mg/kg/day = 40 mg/day total; divided every 12 hours = 20 mg IV every 12 hours.
Acute Spinal Cord Injury Protocol
- Loading dose: 30 mg/kg IV over 15 minutes
- Maintenance infusion: 5.4 mg/kg/hour IV for 23 hours
For a 30 kg child: Loading dose = 30 × 30 mg/kg = 900 mg IV over 15 minutes; Maintenance = 30 × 5.4 mg/kg/hr = 162 mg/hour for 23 hours. Consult institutional protocol regarding maximum infusion doses and weight-based caps for the SCI regimen.
Indications and Clinical Context
General IV methylprednisolone dosing at 2 mg/kg/day divided every 6–12 hours is applicable across a broad spectrum of pediatric inflammatory and allergic conditions, including acute asthma exacerbations, croup refractory to dexamethasone, autoimmune flares, and inflammatory bowel disease. The dose ceiling of 60 mg/dose every 12 hours reflects standard practice to minimize corticosteroid-related adverse effects in children while maintaining therapeutic efficacy.
The acute spinal cord injury protocol—a 30 mg/kg IV bolus followed by a 5.4 mg/kg/hour infusion for 23 hours—is based on the NASCIS II/III study design and remains a consideration in select pediatric SCI cases within specific time windows from injury. Clinicians should note that the use of high-dose methylprednisolone for acute SCI remains controversial and is not uniformly endorsed by all current guidelines; its application should follow institutional neurosurgical and critical care consensus.
Administration and Monitoring
Methylprednisolone is administered intravenously for acute indications. The general dosing regimen may be given as a slow IV push or short infusion per institutional practice. The spinal cord injury loading dose must be infused over exactly 15 minutes, followed immediately by the maintenance infusion; bolus administration faster than recommended may increase the risk of cardiovascular adverse effects. Monitor closely for hypertension, hyperglycemia, and electrolyte disturbances—particularly hypokalemia—during high-dose infusions.
- Monitor blood glucose frequently during and after high-dose administration
- Assess blood pressure and heart rate throughout the SCI infusion protocol
- Use with caution in patients with active infection, GI bleeding, or known adrenal suppression
- Taper prolonged courses to prevent adrenal insufficiency; abrupt discontinuation after extended therapy is not recommended
- Consult institutional protocol for weight-based maximum dose limits not explicitly stated in source guidelines
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.